- Home
- AIT vs QGEN Comparison
AIT vs QGEN Comparison
Compare AIT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIT
- QGEN
- Stock Information
- Founded
- AIT 1923
- QGEN 1986
- Country
- AIT United States
- QGEN Netherlands
- Employees
- AIT N/A
- QGEN N/A
- Industry
- AIT Industrial Machinery/Components
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIT Industrials
- QGEN Health Care
- Exchange
- AIT Nasdaq
- QGEN Nasdaq
- Market Cap
- AIT 9.8B
- QGEN 9.9B
- IPO Year
- AIT N/A
- QGEN 1996
- Fundamental
- Price
- AIT $218.81
- QGEN $38.91
- Analyst Decision
- AIT Strong Buy
- QGEN Buy
- Analyst Count
- AIT 8
- QGEN 8
- Target Price
- AIT $289.38
- QGEN $49.79
- AVG Volume (30 Days)
- AIT 293.9K
- QGEN 1.2M
- Earning Date
- AIT 04-24-2025
- QGEN 04-28-2025
- Dividend Yield
- AIT 0.84%
- QGEN 3.38%
- EPS Growth
- AIT 3.70
- QGEN N/A
- EPS
- AIT 9.88
- QGEN 0.37
- Revenue
- AIT $4,479,010,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- AIT $3.03
- QGEN $5.15
- Revenue Next Year
- AIT $6.96
- QGEN $6.49
- P/E Ratio
- AIT $22.14
- QGEN $105.14
- Revenue Growth
- AIT 0.37
- QGEN 0.66
- 52 Week Low
- AIT $177.68
- QGEN $37.63
- 52 Week High
- AIT $282.98
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- AIT 26.32
- QGEN 41.25
- Support Level
- AIT $222.54
- QGEN $38.76
- Resistance Level
- AIT $230.90
- QGEN $39.86
- Average True Range (ATR)
- AIT 7.40
- QGEN 0.71
- MACD
- AIT -2.41
- QGEN 0.23
- Stochastic Oscillator
- AIT 1.19
- QGEN 51.20
About AIT Applied Industrial Technologies Inc.
Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).